T/CRHA 097-2024 Individualized Antitumor Drug Sensitivity Detection Technique Specification for Human-Derived Tumor Organoids

Scope

Scope: This document specifies the general requirements for drug sensitivity testing of tumor organoids in clinical applications, including experimental procedures, waste disposal, data management, and quality control. Main technical content: The overall structure of this document is as follows: 1. Scope; 2. Normative reference documents; 3. Terms and definitions; 4. Abbreviations; 5. General requirements; 6. Experimental procedures; 7. Waste disposal; 8. Data management; 9. Quality control. This document is applicable to the culturing and subculturing of human tumor organoids, as well as drug sensitivity testing of targeted drugs and chemotherapy drugs.

Development Information

Related Standards